1995
DOI: 10.1016/0167-4781(94)00179-7
|View full text |Cite
|
Sign up to set email alerts
|

Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0
1

Year Published

1996
1996
2007
2007

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(19 citation statements)
references
References 28 publications
1
17
0
1
Order By: Relevance
“…SSCP has been used to identify point mutations in a number of genes (23-25) and PCR-SSCP recently has been used to iden- tify mutations in CD40 ligand (28). The present experiments use SSCP to screen patients with SLE for a defect in the fourth exon of FasL and a heterozygous mutation was found in 1 of 75 patients, but in none of the 52 normal control patients.…”
Section: Discussionmentioning
confidence: 99%
“…SSCP has been used to identify point mutations in a number of genes (23-25) and PCR-SSCP recently has been used to iden- tify mutations in CD40 ligand (28). The present experiments use SSCP to screen patients with SLE for a defect in the fourth exon of FasL and a heterozygous mutation was found in 1 of 75 patients, but in none of the 52 normal control patients.…”
Section: Discussionmentioning
confidence: 99%
“…Seven fixed differences between human and chimpanzees are underlined and labelled 'X in chimps'. Discrepancies with previously published sequence (14) are underlined and labelled 'X found'. Three single nucleotide polymorphisms are underlined and labelled 'X/Y polymorphism'.…”
Section: Figurementioning
confidence: 99%
“…This approach has the advantage that it can be used to provide carrier detection when the proband is no longer living or in families with sporadic X-linked hyper IgM syndrome when the origin of the mutation is not known. A single mutation in CD40 ligand found by SSCP screening has been reported (24); however, it is not clear what proportion of mutations in CD 40 ligand can be detected by SSCP screening.…”
Section: Introductionmentioning
confidence: 99%